Molecular Depletion of Descending Serotonin Unmasks Its Novel Facilitatory Role in the Development of Persistent Pain
Authors:
- Feng WeiFWFeng Wei
- Ronald DubnerRDRonald Dubner
- Shiping ZouSZShiping Zou
- K. RenKRK. Ren
- Guang BaiGBGuang Bai
- Dong WeiDWDong Wei
- Wei GuoWGWei Guo
- 23 June 2010
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 30 (25) , 8624-8636
Abstract
Recent studies indicate that persistent pain after tissue or nerve injury is accompanied by an enhanced net descending facilitatory drive that contributes to an amplification and spread of pain. Although 5-HT-containing neurons in the rostral ventromedial medulla (RVM) provide the major descending serotonergic projection to the spinal cord, it is not clear whether the neurotransmitter 5-HT itself released from RVM-spinal neurons contributes to descending pain modulation. In the present study, we determined the role of the descending 5-HT in rat nocifensive behaviors after persistent pain by selectively depleting functional phenotypes of 5-HT in RVM neurons with regional shRNA interference (RNAi) of tryptophan hydroxylase-2 (Tph-2), the rate-limiting enzyme in the synthesis of neuronal 5-HT. Compared to negative control shRNA, Tph-2 shRNA induced significantly prolonged downregulation of Tph-2 in the RVM and 5-HT in spinal dorsal horn. The 5-HT-depleted rats showed normal pain sensitivity in responses to acute noxious stimulation. However, the same RNAi treatment attenuated formalin-induced spontaneous nocifensive responses and tissue or nerve injury-induced allodynia and hyperalgesia. Furthermore, in control shRNA-treated animals, intra-RVM microinjection of brain-derived neurotrophic factor produced a reversible hyperalgesia, which was completely prevented by Tph-2 RNAi pretreatment. Descending inhibition induced by intra-RVM electrical stimulation, but not microinjection of the μ- or κ-opioid receptor agonists in control shRNA-treated animals was eliminated in 5-HT-depleted rats. These results indicate that the descending 5-HT from the RVM is an important contributor to pain facilitation during the development of persistent pain, and may not mediate opioid-induced descending inhibition in acute pain.Keywords
This publication has 78 references indexed in Scilit:
- Cellular basis for opioid potentiation in the rostral ventromedial medulla of rats with persistent inflammatory nociceptionPain, 2010
- Purinergic receptor immunoreactivity in the rostral ventromedial medullaNeuroscience, 2009
- Descending Serotonergic Controls Regulate Inflammation-Induced Mechanical Sensitivity and Methyl-CpG-Binding Protein 2 Phosphorylation in the Rat Superficial Dorsal HornMolecular Pain, 2008
- Sensitization of Pain-Modulating Neurons in the Rostral Ventromedial Medulla after Peripheral Nerve InjuryThe Journal of Neuroscience, 2007
- Immunolabelling of the 5‐HT3B receptor subunit in the central and peripheral nervous systems in rodentsEuropean Journal of Neuroscience, 2007
- Role of TPH‐2 in brain function: News from behavioral and pharmacologic studiesJournal of Neuroscience Research, 2007
- Descending serotonergic facilitation of spinal ERK activation and pain behaviorFEBS Letters, 2006
- An excitatory role for 5-HT in spinal inflammatory nociceptive transmission; state-dependent actions via dorsal horn 5-HT3 receptors in the anaesthetized ratPain, 2000
- Effects of Four Herbal Extracts on Adjuvant-Induced Inflammation and Hyperalgesia in RatsThe Journal of Alternative and Complementary Medicine, 1999
- Microinjection of morphine into the periaqueductal gray evokes the release of serotonin from spinal cordBrain Research, 1979